+Search query
-Structure paper
Title | Design, Synthesis, and Characterization of an Orally Active Dual-Specific ULK1/2 Autophagy Inhibitor that Synergizes with the PARP Inhibitor Olaparib for the Treatment of Triple-Negative Breast Cancer. |
---|---|
Journal, issue, pages | J. Med. Chem., Vol. 63, Page 14609-14625, Year 2020 |
Publish date | Apr 1, 2020 (structure data deposition date) |
Authors | Ren, H. / Bakas, N.A. / Vamos, M. / Chaikuad, A. / Limpert, A.S. / Wimer, C.D. / Brun, S.N. / Lambert, L.J. / Tautz, L. / Celeridad, M. ...Ren, H. / Bakas, N.A. / Vamos, M. / Chaikuad, A. / Limpert, A.S. / Wimer, C.D. / Brun, S.N. / Lambert, L.J. / Tautz, L. / Celeridad, M. / Sheffler, D.J. / Knapp, S. / Shaw, R.J. / Cosford, N.D.P. |
External links | J. Med. Chem. / PubMed:33200929 |
Methods | X-ray diffraction |
Resolution | 2.7 Å |
Structure data | PDB-6yid: |
Chemicals | ChemComp-EDJ: ChemComp-HOH: |
Source |
|
Keywords | TRANSFERASE / kinase / kinase inhibitor / ULK2 / autophagy / chemical probe / Structural Genomics / Structural Genomics Consortium / SGC |